Recently, dietary supplementation with ribitol was shown to improve muscle phenotypes in a mouse model of FKRP-related α-dystroglycanopathy (Cataldi et al., 2018). Here, FKRP is linked to neuromuscular disease caused by qualitative or quantitative defects of alpha-dystroglycan.